Genetic Alterations in Primary Melanoma in Taiwan.
By: Y-S Sheen, K-T Tan, K-P Tse, Y-H Liao, M-H Lin, J-S Chen, J-Y Liau, Y-J Tseng, C-H Lee, C-H Hong, J-B Liao, H-T Chang, C-Y Chu

Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
2019-8-14; doi: 10.1111/bjd.18425
Abstract

Background

Acral melanoma (AM) is the most common histopathological subtype of malignant melanoma in Asians. However, differences in the mutational profiles underlying AM and non-acral cutaneous melanoma (NAM) in Asians are not well understood.

Objectives

To augment the understanding of the prevalence, patterns, and associations of various mutations between different subtypes of melanoma.

Methods

We performed comprehensive genomic profiling of 409 cancer-associated genes, using next-generation sequencing, in 66 primary melanomas comprised of 45 AMs and 21 NAMs.

Results

Most of the AMs (27/45, 60%), but only 5 of 21 (23·8%) NAMs were the Triple wild-type (Triple-WT) tumors. Compared with the AMs, the NAMs exhibited a significantly higher frequency of BRAF mutation. Meanwhile, the frequencies of NRAS/KRAS mutations, cell cycle aberrations, copy number gains of BIRC2/3/5, and gains of receptor tyrosine kinase genes were significantly higher in the AMs. Ulceration was found at significantly higher rates in the AMs and NAMs with cell cycle aberrations and gains of receptor tyrosine kinase genes. Notably, cell cycle aberrations and copy number gains of BIRC2/3/5 were significantly associated with poor melanoma-specific survival in all 66 melanoma patients and especially in the 45 AM patients. Furthermore, a multivariate analysis showed that lymph node metastasis and cell cycle aberrations were independent prognostic factors for melanoma-specific survival.

Conclusions

This study strengthens our understanding of the patterns and clinical associations of oncogenic mutations in AMs and NAMs in Asians. This article is protected by copyright. All rights reserved.



This article is protected by copyright. All rights reserved.

PMID:31408190






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements